U.S. Wireless Telecom Stock News

First National Bank Alaska reported first-quarter 2026 results showing net interest income of US$48.98 million and net income of US$21.17 million, both higher than a year earlier, and the board declared a US$4.00 per share cash dividend for the second quarter, payable on June 15, 2026. This combination of stronger earnings and a maintained quarterly cash dividend highlights the bank’s ability to generate profit while continuing to return cash to shareholders. Next, we will examine how the...

In early May 2026, US Foods Holding Corp. reported modest year-on-year first-quarter growth in sales and earnings, completed a US$983.6 million buyback program, and reaffirmed its 2026 net sales growth outlook of 4% to 6% despite weather and fuel headwinds. The company also highlighted continued market share gains and an active capital deployment agenda, including further share repurchases and tuck-in acquisitions funded by ongoing cash generation. Against this backdrop, we'll examine how...

First quarter earnings and guidance catch investor attention Royal Caribbean Cruises (RCL) has drawn fresh interest after reporting first quarter 2026 results with higher revenue and net income versus a year earlier, alongside full year guidance pointing to roughly 10% revenue growth. See our latest analysis for Royal Caribbean Cruises. RCL shares closed at US$264.20 and, despite a 2.36% 1 day share price gain after the earnings and guidance update plus the announced US$1.50 quarterly...

Agilent Technologies (A) has been active on several fronts recently, from new collaborations in biopharma analytics to the launch of its 16850 Series portable logic analyzers, giving investors fresh context for assessing the stock. See our latest analysis for Agilent Technologies. Despite fresh product launches and new biopharma collaborations shaping sentiment, Agilent’s share price has eased recently. The 30-day share price return is down 4.05% and the year-to-date share price return is...

In the first quarter of 2026, ADTRAN Holdings, Inc. reported revenue of US$286.09 million and a net loss of US$1.32 million, alongside issuing second-quarter revenue guidance of US$283.0 million to US$303.0 million and disclosing recent stock option exercises and share sales by its Chief Technology Officer. The combination of year-over-year revenue growth, a sharply smaller net loss, and quantified near-term revenue expectations gives investors clearer insight into ADTRAN’s operating...

Aura Minerals Inc. has already reported first-quarter 2026 results, with sales rising to US$382.61 million and net income reaching US$95.16 million, alongside record gold-equivalent production of 82,100 ounces driven by the MSG acquisition and Borborema’s ramp-up. The company also began construction of its Era Dorada project after securing permits and board approval, adding another growth option to a portfolio where management is reaffirming 2026 production guidance while highlighting...

Ralph Lauren is curating the USPS American Icons stamp collection, the first time an individual designer has overseen a full official USPS series. The collaboration coincides with preparations for America's 250th anniversary and includes a commemorative capsule collection in Ralph Lauren stores and online. The project links the NYSE:RL brand directly to a high profile national cultural celebration beyond traditional fashion partnerships. For investors tracking NYSE:RL, this project arrives...

In the first quarter of fiscal 2026, Vishay Precision Group reported net revenues of US$84.35 million, a smaller net loss of US$0.319 million compared with a year earlier, and issued second‑quarter revenue guidance of US$85 million to US$90 million, all of which surpassed analyst expectations and reflected broad-based demand across its core segments. Orders exceeded US$100 million, lifting the book-to-bill ratio to 1.21 and backlog to about US$125 million, highlighting strong order...

In May 2026, Definium Therapeutics dosed the first patient in Ascend, its second Phase 3 trial of DT120 ODT for major depressive disorder, a 175‑patient U.S. study assessing changes in Montgomery-Åsberg Depression Rating Scale scores over 12 weeks versus placebo. This milestone extends Definium’s late-stage program for its proprietary fast-dissolve lysergide tablet, aiming to show antidepressant effects while addressing concerns about functional unblinding through a three-arm dosing...

Labcorp Holdings (LH) is back in focus after announcing an expanded collaboration with Epic, embedding its full diagnostic test menu into Epic's Aura platform to simplify ordering and results for hospitals and health systems. See our latest analysis for Labcorp Holdings. Recent share price performance has been softer, with the stock down 8.52% on a 3 month share price basis and 3.69% over 1 month. However, the 1 year total shareholder return of 6.10% and 3 year total shareholder return of...

The Southern Company recently reported past first-quarter 2026 results, with revenue of US$8,397 million and net income of US$1,356 million, and highlighted a US$26.50 billion Department of Energy loan alongside customer savings from Georgia regulatory agreements. Together, these earnings, financing, and bill-reduction developments underscore how Southern is pairing large-scale infrastructure investment with efforts to limit long-term cost pressure for customers. Next, we’ll examine how this...

In May 2026, Teva Pharmaceutical Industries Limited presented at the Bank of America Global Healthcare Conference in Las Vegas and at BioMed Israel in Tel Aviv, highlighting its central nervous system portfolio and research progress through senior executives Eric A. Hughes and Eran Harary. These appearances came shortly after Teva reported that sales from its central nervous system medicines, including Ajovy, Uzedy, and Austedo, rose very large year-on-year to US$837 million in the first...

On May 12, 2026, Alkermes announced positive topline Phase 3 REVITALYZ results showing that once‑nightly LUMRYZ improved excessive daytime sleepiness and other idiopathic hypersomnia symptoms versus placebo, supporting plans to file a supplemental New Drug Application with the FDA by the end of 2026. A key nuance for investors is that, under an existing settlement, Alkermes cannot market LUMRYZ for idiopathic hypersomnia before March 1, 2028, even if it secures earlier FDA approval. We’ll...

Gilead Sciences (NasdaqGS:GILD) plans to present new liver disease data at the upcoming EASL Congress. The company will showcase pivotal Phase 3 results for Livdelzi (seladelpar) in primary biliary cholangitis. Additional updates will cover progress on investigational hepatitis delta virus treatments, including bulevirtide. Gilead Sciences is putting more attention on its liver disease pipeline, which sits alongside its well known HIV and oncology franchises. The stock trades at $133.05,...

Why Fox (FOXA) stock is back in focus after earnings and buybacks Fox (FOXA) is back on investors’ radar after a solid earnings surprise and an update on its long running share repurchase program, combining operating resilience with sizeable capital returns. See our latest analysis for Fox. Fox’s earnings beat, renewed buyback activity and upcoming conference appearance have arrived alongside a 17.79% 90 day share price return, while the stock’s 1 year total shareholder return of 22.81% sits...

Earlier in May 2026, LeMaitre Vascular, Inc. reported first-quarter sales of US$66.55 million and net income of US$15.68 million, raised its full-year 2026 sales and earnings guidance, and its board approved a US$0.25 quarterly dividend payable on June 4, 2026. These stronger results and upgraded outlook, alongside upcoming investor outreach at the Bank of America Global Healthcare Conference, highlight management’s confidence in the company’s operating trajectory and cash-generating...

Ondas Inc. has already reported that it will release its Q1 2026 results and host an earnings call on May 14, 2026, alongside completing a US$175.00 million merger with defense prime contractor Mistral Inc. that expands its access to U.S. military contract channels and domestic manufacturing capabilities. Recent contract wins, including a US$10.00 million initial demining order for Israel’s Eastern Border Security Barrier via subsidiary 4M Defense, underscore how Ondas is repositioning...

SEI Investments (NasdaqGS:SEIC) and Carlyle have expanded their partnership to broaden private markets access for wealth and retirement investors. The collaboration focuses on developing new private market solutions and joint offerings for wealth management and retirement channels. The move reflects a material change in SEI Investments' approach to private markets within its product lineup. SEI Investments operates across investment processing, investment management, and investment...

If you are wondering whether Waters at around US$334.93 is offering good value or if the market is pricing in too much optimism, this article breaks down what the current share price may be implying. The stock has been choppy, with the price falling 4.2% over the last week, rising 3.2% over the last month, and still sitting down 12.3% year to date and down 3.0% over the past year, alongside a 26.9% gain over three years and 9.3% over five years. Recent coverage has focused on how these mixed...

Why Clean Harbors stock is drawing fresh attention Clean Harbors (CLH) is back on investors’ radar after a strong past 3 months, with the stock up about 13.5% and trading near its recent close of US$302.95. That move sits alongside full year revenue of US$6.06b and net income of US$395.50m, giving investors concrete figures to weigh against the company’s current valuation and recent share price momentum. See our latest analysis for Clean Harbors. Beyond the recent 3 month move, the stock’s 1...

ZIM Integrated Shipping Services is at the center of a takeover contest, with competing interest from Hapag-Lloyd and Sakal Group. ZIM's board has reaffirmed support for its binding merger agreement with Hapag-Lloyd, despite a higher offer from Sakal Group. Hapag-Lloyd has made commitments regarding Israeli operations and staff as part of its proposed merger with ZIM. For investors watching NYSE:ZIM, the merger contest arrives after a period of strong multi year share performance, with the...

Recent performance snapshot Lennar (LEN) has been under pressure recently, with the stock down about 1% over the past day, 6% over the past week, and roughly 5% over the past month. The decline is steeper over the past 3 months, with the share price down about 30%, contributing to a year to date fall of around 18% and a 1 year total return decline of about 20%. See our latest analysis for Lennar. With the share price at $84.97, Lennar’s recent weakness, including a 90 day share price return...

Chewy stock reaction and recent performance Chewy (CHWY) has been in focus after recent trading, with the stock closing at US$21.65. Investors are weighing this move against a share price that is down over the past month. See our latest analysis for Chewy. The recent 1 day share price decline of 5.46% extends a weak run, with the 30 day share price return down 14.63% and the 1 year total shareholder return down 47.18%. This suggests momentum has been fading as investors reassess Chewy's risk...

Wondering whether Nutanix at around US$44.50 is priced for opportunity or risk? This article breaks down what the current share price may be implying about the stock's value. The stock recently closed at US$44.50, with returns of 3.2% over the past week and 19.3% over the past month, while being down 12.1% year to date and 45.6% over the last year, compared with a 69.4% gain over three years and a 50.5% gain over five years. Recent headlines around Nutanix have focused on its positioning...